DAX23.163 -0,1%Est505.542 +0,1%MSCI World4.343 -0,1%Top 10 Crypto12,20 -4,7%Nas22.578 +0,7%Bitcoin76.839 -4,1%Euro1,1525 -0,5%Öl63,49 -2,1%Gold4.074 +0,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Rheinmetall 703000 DroneShield A2DMAA RENK RENK73 Siemens Energy ENER6Y Amazon 906866 Deutsche Telekom 555750 TKMS thyssenkrupp Marine Systems TKMS00 Lufthansa 823212 Siemens 723610 Alphabet A (ex Google) A14Y6F Plug Power A1JA81 Tesla A1CX3T SAP 716460 BASF BASF11
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Hochspannung vor NVIDIA-Zahlen -- Wall Street verhalten -- DAX beendet Handel stabil -- Mercedes-Benz, Siemens Energy, Rheinmetall, TKMS, DroneShield, Plug Power im Fokus
Top News
Kontoführungsgebühren steigen - und viele zahlen stillschweigend mit Kontoführungsgebühren steigen - und viele zahlen stillschweigend mit
NVIDIA-Aktie vor den Quartalszahlen: Sollten Anleger noch zugreifen oder in Deckung gehen? NVIDIA-Aktie vor den Quartalszahlen: Sollten Anleger noch zugreifen oder in Deckung gehen?
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Für spannende Renditechancen in Schwellenländern: Mit diesem Amundi ETF kannst du einfach und günstig investieren.

Eli Lilly Aktie

Kaufen
Verkaufen
Eli Lilly Aktien-Sparplan
910,00 EUR +17,40 EUR +1,95 %
STU
1.050,42 USD +19,96 USD +1,94 %
BTT
Eli Lilly jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.833,97 Mrd. EUR

KGV65,91Div. Rendite0,67%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN858560

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS5324571083

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolLLY

Eli Lilly Aktien News

DatumMeistgelesen
EN, Eli LillyLilly announces plans to open Lilly Gateway Labs site in Philadelphia
PR NewswireLilly announces plans to open Lilly Gateway Labs site in Philadelphia
PR NewswireLilly to participate in Citi's 2025 Global Healthcare Conference
Wer­bungEli Lilly-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
EN, Eli LillyLilly to participate in Citi's 2025 Global Healthcare Conference
EN, Eli LillyStatement: Eli Lilly has no affiliation with Mangoceuticals, Inc.
EN, Eli LillyQueer Eye's Tan France helps unthread obesity bias as part of Zepbound's (tirzepatide) 'Changing the Thread Collection'
PR NewswireQueer Eye's Tan France helps unthread obesity bias as part of Zepbound's (tirzepatide) 'Changing the Thread Collection'
PR NewswireLilly announces two new Executive Committee members and expansion of leadership roles to prepare for next wave of growth
EN, Eli LillyLilly announces two new Executive Committee members and expansion of leadership roles to prepare for next wave of growth
EN, Eli LillyLilly and U.S. government agree to expand access to obesity medicines to millions of Americans
PR NewswireLilly and U.S. government agree to expand access to obesity medicines to millions of Americans
EN, Eli LillyLilly's selective amylin agonist, eloralintide, demonstrated meaningful weight loss and favorable tolerability in a Phase 2 study of adults with obesity or overweight
PR NewswireLilly's selective amylin agonist, eloralintide, demonstrated meaningful weight loss and favorable tolerability in a Phase 2 study of adults with obesity or overweight
PR NewswireLilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide
PR NewswireLilly plans to build a new €2.6 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide
EN, Eli LillyLilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide
EN, Eli LillyLilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance
PR NewswireLilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance
EN, Eli LillyLilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United States
PR NewswireLillyDirect and Walmart Pharmacy launch first retail pick-up option with direct-to-consumer pricing for Zepbound
EN, Eli LillyLillyDirect and Walmart Pharmacy launch first retail pick-up option with direct-to-consumer pricing for Zepbound
EN, Eli LillyLilly partners with NVIDIA to build the industry's most powerful AI supercomputer, supercharging medicine discovery and delivery for patients
PR NewswireLilly partners with NVIDIA to build the industry's most powerful AI supercomputer, supercharging medicine discovery and delivery for patients
PR NewswireLilly announces roster of Team USA athletes for the Olympic and Paralympic Games Milano Cortina 2026, pledges to translate U.S. Olympic and Paralympic milestones into meaningful community impact
EN, Eli LillyLilly announces roster of Team USA athletes for the Olympic and Paralympic Games Milano Cortina 2026, pledges to translate U.S. Olympic and Paralympic milestones into meaningful community impact
PR NewswireLilly's Omvoh (mirikizumab-mrkz) approved by U.S. FDA as a single-injection maintenance regimen in adults with ulcerative colitis
EN, Eli LillyLilly's Omvoh (mirikizumab-mrkz) approved by U.S. FDA as a single-injection maintenance regimen in adults with ulcerative colitis
PR NewswireLilly declares fourth-quarter 2025 dividend
EN, Eli LillyLilly declares fourth-quarter 2025 dividend
PR NewswireLilly Drafts Shaquille O'Neal to Raise Awareness for Moderate-to-Severe Obstructive Sleep Apnea
EN, Eli LillyLilly Drafts Shaquille O'Neal to Raise Awareness for Moderate-to-Severe Obstructive Sleep Apnea
EN, Eli LillyLilly's Omvoh (mirikizumab-mrkz) demonstrated early and sustained improvement in bowel urgency outcomes for patients with ulcerative colitis
PR NewswireLilly's Omvoh (mirikizumab-mrkz) demonstrated early and sustained improvement in bowel urgency outcomes for patients with ulcerative colitis
EN, Eli LillyLilly to Acquire Adverum Biotechnologies
PR NewswireLilly to Acquire Adverum Biotechnologies
EN, Eli LillyLilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial
EN, Eli LillyLilly's EBGLYSS (lebrikizumab-lbkz) delivered durable disease control when administered once every eight weeks in patients with moderate-to-severe atopic dermatitis
PR NewswireLilly's EBGLYSS (lebrikizumab-lbkz) delivered durable disease control when administered once every eight weeks in patients with moderate-to-severe atopic dermatitis
PR NewswireLilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial
EN, Eli LillyLilly's Verzenio® (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment

Eli Lilly News

Eli Lilly News: auf dieser Seite finden Sie alle Eli Lilly News und Nachrichten zur Eli Lilly Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Eli Lilly News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Eli Lilly News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.